Bristol-Myers Looks To Ax Investor Suit Over Clinical Trial
Bristol-Myers Squibb asked a New York federal judge on Tuesday to toss a proposed class action alleging it misled investors about the clinical trial patients for its new lung cancer drug,...To view the full article, register now.
Already a subscriber? Click here to view full article